• U.S. Burden of Skin and Subcutaneous Diseases Increasing

    Healthday News Conditions, HealthDay News Physician's Briefing June 25, 2020
  • Can dermatology employers require employees to receive the COVID-19 vaccine?

    American Academy of Dermatology AAD, Conditions, Coronavirus, COVID-19 January 28, 2021
  • THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

    American Academy of Dermatology AAD, Atopic Dermatitis, Conditions, Dermatology January 26, 2021
  • Expression of retinoid receptors in hand eczema.

    ClinOwl Atopic Dermatitis, ClinOwl, Conditions, Eczema October 1, 2020
  • S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

    Healthday News Atopic Dermatitis, Conditions, Eczema July 28, 2020
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

    ClinOwl ClinOwl, Conditions, COVID-19, Psoriasis July 26, 2020

DermConnect® is an official licensee of the American Academy of Dermatology.

DermConnect®
Navigation
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
Home Posts Coronavirus

Category Archive

  • Coronavirus / October 4, 2020

    The impact of COVID-19 control measures on social contacts and transmission in Kenyan informal settlements.

    View Post
  • Coronavirus / October 5, 2020

    Pattern of disinfectants use and their adverse effects on the consumers after COVID-19 outbreak.

    View Post
  • Coronavirus / October 10, 2020

    Eosinophilic folliculitis due to wearing protective gear in citizens volunteering for sanitation services during the COVID-19 pandemic – an original epidemiological, clinical, dermoscopic, and laboratory-based study.

    View Post
  • Coronavirus / October 6, 2020

    Systemic Medications of Dermatological Importance in COVID-19.

    View Post
  • Coronavirus / November 15, 2020

    Electronic learning for Healthcare (e-LfH) e-Dermatology modules as a key educational tool for trainees during the COVID-19 pandemic: a regional experience.

    View Post

Response to “Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic”.

In Coronavirus
by ClinOwl
November 5, 2020

we noted with interest the recent letter by Earnshaw and colleagues documenting decreased skin cancer referrals to their dermatology department and report a similar phenomenon seen in Ireland on a …

Dermatologic manifestations of COVID-19: a comprehensive systematic review.

In Coronavirus
by ClinOwl
November 3, 2020

Recent reports have suggested that there may be dermatologic manifestations of COVID-19. We searched 12 databases for peer-reviewed or pre-print published studies until July 15, 2020, for this PRISMA-compliant review …

Chilblains-like lesions and SARS-CoV-2 in children: an overview in therapeutic approach.

In Coronavirus
by ClinOwl
November 3, 2020

SARS-CoV-2 (Severe Acute Respiratory Syndrome, Coronavirus, type 2) is the virus responsible for the global pandemic of Coronavirus disease 2019 (COVID-19) that began in China in December 2019. The variability …

Chilblain-like lesions with prominent bullae in a patient with COVID-19.

In Coronavirus
by ClinOwl
November 3, 2020

A 27-year-old patient presented with acral chilblain-like lesions atypical of dermatological presentations appearing in current reports of COVID-19. Prominent bullae had formed on the dorsa of her toes and became …

ACE2 Netlas: In-silico functional characterization and drug-gene interactions of ACE2 gene network to understand its potential involvement in COVID-19 susceptibility.

In Coronavirus
by ClinOwl
November 3, 2020

Angiotensin-converting enzyme-2 ( ACE2 ) receptor has been identified as the key adhesion molecule for the transmission of the SARS-CoV-2. However, there is no evidence that human genetic variation in …

Self-reported cutaneous manifestations in 1,429 Brazilian COVID-19 patients.

In Coronavirus
by ClinOwl
November 2, 2020

Most data on cutaneous manifestations of COVID-19 rely on the evaluation of hospitalized patients. Conversely as COVID-19 requires social isolation many low-symptomatic individuals develop dermatologic manifestations which prevalence is underestimated. …

5-Alpha-Reductase Inhibitors are Associated with Reduced Frequency of COVID-19 Symptoms in Males with Androgenetic Alopecia.

In Coronavirus
by ClinOwl
November 2, 2020

We have previously reported that men with androgenetic alopecia (AGA) are more likely to present with severe COVID-19 symptoms, potentially implicating androgen sensitivity as a risk factor for COVID-19.1-3 As …

Multicenter study evaluating the impact of COVID-19 outbreak on dermatology outpatients in Turkey.

In Coronavirus
by ClinOwl
November 2, 2020

COVID-19 pandemic has a significant impact on public health, whether directly or indirectly. The first case was seen in Turkey on March 11, and the World Health Organization (WHO) declared …

A paradigm shift in trainee confidence in teledermatology and virtual working during the Covid-19 pandemic: results of a follow-up UK-wide survey.

In Coronavirus
by ClinOwl
November 1, 2020

The entire landscape of dermatology service provision has been transformed by the current Sars-Cov-2 pandemic we find ourselves amidst, with virtual working having become the new norm across the UK. …

Is it time for dermatologists to review our professional consumer-brand relationships?

In Coronavirus
by ClinOwl
October 31, 2020

The coronavirus pandemic and global political movements in 2020 have highlighted the health and societal discrepancies (1) between different socioeconomic groups, gender, and ethnicities. Global campaigns such as “Pull Up …

  • Page 2 of 6
  • ←
  • 1
  • 2
  • 3
  • ...
  • 6
  • →

TRENDING

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease
  • Lymph Node Dissection Declining in SLN-Positive Melanoma
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

LATEST ARTICLES

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus March 16, 2022
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites March 11, 2022
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease March 11, 2022
  • Lymph Node Dissection Declining in SLN-Positive Melanoma March 9, 2022
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down March 9, 2022

Quick Links

  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

SCHEDULE

May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Mar    

All content indicated on this website as authored by "AAD" is owned by and licensed with the permission of the American Academy of Dermatology (“AAD”) for personal educational use.

The content may not be distributed in whole or in part to any third parties without express written permission from AAD,
nor may viewers of this site translate, edit, modify or otherwise create derivative works from the content.

The licensing of the content by AAD does not constitute or imply any endorsement of any company and/or any of its goods, services or written work product.

 

  • Home
  • Atopic Dermatitis
  • Psoriasis
  • Skin Cancer